Related Experiment Video
Updated: Aug 4, 2026

08:37
Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog
Published on: November 5, 2014
Substituted coumarins as esterase-sensitive prodrug moieties with improved release rates
Bioorganic & Medicinal Chemistry Letters
|July 16, 1999
Summary
Researchers developed new coumarin-based prodrugs for faster drug release. These improved esterase-sensitive prodrugs enhance the delivery of amines and peptides.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Drug Delivery Systems
Background:
- A previously reported coumarin-based prodrug system enables the preparation of esterase-sensitive prodrugs for amines, peptides, and peptidomimetics.
- The release kinetics of the prior system were found to be undesirably slow for certain drug moieties.
Purpose of the Study:
- To synthesize and evaluate novel substituted coumarin-based prodrugs.
- To achieve significantly increased drug release rates compared to the previous system.
Main Methods:
- Synthesis of various substituted coumarin derivatives.
- Evaluation of the prodrugs' stability and release kinetics using model amines.
- Spectroscopic and chromatographic techniques for characterization and quantification.
Main Results:
- Several novel substituted coumarin-based prodrugs were successfully synthesized and characterized.
- The newly developed prodrugs demonstrated significantly accelerated release rates of the parent amines compared to the earlier system.
- Structure-activity relationship studies indicated key substituents influencing release kinetics.
Conclusions:
- The modified coumarin-based prodrugs offer a viable strategy for enhancing the release of amine-containing drugs.
- These prodrugs represent an improvement over the previous system, particularly for moieties requiring faster drug liberation.
- Further investigation into diverse drug moieties and in vivo studies are warranted.
Related Concept Videos
Prodrugs
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Bioavailability
Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...
Modified-Release Drug Delivery Systems: Drug Release Characteristics
Drug release from modified-release dosage forms is designed to achieve specific therapeutic effects by controlling the rate and extent of drug release. The classification of these drug release systems is based on key pharmacokinetic assumptions: drug disposition follows first-order kinetics, drug release is the rate-limiting step in absorption, and the released drug is rapidly and completely absorbed.There are four major models of drug release patterns. The first model is the slow zero-order...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

